Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Jumadilova, Zhanna"'
Autor:
Morimoto, Kozo, Nonaka, Mizu, Yamazaki, Yoshitaka, Nakagawa, Taku, Takasaki, Jin, Tsuyuguchi, Kazunari, Kitada, Seigo, Jumadilova, Zhanna, Yuen, Dayton W., Ciesielska, Monika, Hasegawa, Naoki
Publikováno v:
In Respiratory Investigation March 2024 62(2):284-290
Autor:
Bilton, Diana, Fajac, Isabelle, Pressler, Tacjana, Clancy, John Paul, Sands, Dorota, Minic, Predrag, Cipolli, Marco, Galeva, Ivanka, Solé, Amparo, Quittner, Alexandra L., Jumadilova, Zhanna, Ciesielska, Monika, Konstan, Michael W.
Publikováno v:
In Journal of Cystic Fibrosis November 2021 20(6):1010-1017
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Benner, Joshua S., Becker, Russell, Fanning, Kristina, Jumadilova, Zhanna, Bavendam, Tamara, Brubaker, Linda †, ‡
Publikováno v:
In The Journal of Urology 2009 181(6):2591-2598
Autor:
Coyne, Karin S. *, Margolis, Mary Kay, Jumadilova, Zhanna, Bavendam, Tamara, Mueller, Elizabeth, Rogers, Rebecca
Publikováno v:
In The Journal of Sexual Medicine May 2007 4(3):656-666
Autor:
Jumadilova, Zhanna1 zhanna.jumadilova@pfizer.com, Varadharajan, Sujata2,3, Girase, Prafulla4, Ollendorf, Daniel A.5
Publikováno v:
American Journal of Health-System Pharmacy. 12/1/2006, Vol. 63 Issue 23, p2357-2364. 8p. 3 Charts.
Publikováno v:
In Chest October 2020 158(4) Supplement:A315-A315
Publikováno v:
In Chest October 2020 158(4) Supplement:A312-A312
Autor:
Morimoto, Kozo, Nonaka, Mizu, Yamazaki, Yoshitaka, Nakagawa, Taku, Takasaki, Jin, Tsuyuguchi, Kazunari, Kitada, Seigo, Jumadilova, Zhanna, Yuen, Dayton W., Ciesielska, Monika, Hasegawa, Naoki
Publikováno v:
Respiratory Investigation; 20240101, Issue: Preprints
Autor:
Malhotra, Bimal, Dickins, Maurice, Alvey, Christine, Jumadilova, Zhanna, Li, Xiaoxi, Duczynski, Gregory, Gandelman, Kuan
Available data suggest that fesoterodine dosage should not exceed 4 mg once daily when taken concomitantly with potent CYP3A4 inhibitors, such as ketoconazole. Currently, no information is available on whether dose adjustment is necessary when fesote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d4a17305b5108b9cb29b0852fd9d437
https://europepmc.org/articles/PMC3162656/
https://europepmc.org/articles/PMC3162656/